Investment Opportunity in a Biotech Startup and Healthcare Field
myGenomics is a Biotech startup as Next Generation Sequencing (NGS) service provider with specialties ranging from genetic testing, custom target sequencing, disease specific gene panels, RNA sequencing to workflow solutions and project consultation. myGenomics successfully completed the second year in April 2016 with a shining outlook. As myGenomics grows, we welcome discussions with interested investors who share our vision to advance basic and translational research and improve clinical standards.
Next generation sequencing market is currently in an exponential growth phase and market research reports anticipate this market to grow 30 fold in next 5 years. Market size in 2015 was 1$ billion and anticipated to capture $28 billion in 2022.
For serious inquires, please contact us: